Risk of a recurrent VTE during anticoagulant therapy should not be dismissed

The long-term risk for recurrent venous thromboembolism (VTE) in patients on extended anticoagulation is “low but not negligible” and both clinicians and patients should be aware of it, researchers say. An international analysis of data from 26 studies investigated recurrent VTE among patients after a first unprovoked VTE, who after having completed three months of ...

Already a member?

Login to keep reading.

© 2021 the limbic